These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 14481385)
1. Penicillamine as lead-chelating substance in man. OHLSSON WT Br Med J; 1962 May; 1(5290):1454-6. PubMed ID: 14481385 [No Abstract] [Full Text] [Related]
2. Lead excretion following oral dlpenicillamine with a method for comparing the relative effectiveness of chelating agents on the excretion of lead. MOSSER RS; BESSMAN SP Bull Sch Med Univ Md; 1960 Jul; 45():47-9. PubMed ID: 14424633 [No Abstract] [Full Text] [Related]
3. Treatment of lead-poisoning with oral penicillamine. GOLDBERG A; SMITH JA; LOCHHEAD AC Br Med J; 1963 May; 1(5340):1270-5. PubMed ID: 13948657 [No Abstract] [Full Text] [Related]
4. Penicillamine: the pharmacology of a chelating agent. WALSHE JM Ann Intern Med; 1960 Nov; 53():1090-6. PubMed ID: 13782930 [No Abstract] [Full Text] [Related]
5. [Therapeutic effects of D-penicillamine in 3 cases of lead poisoning]. PEROL R; GRAVELEAU J; POTTER M; MORIN M Sem Hop; 1962 Oct; 38():3342-7. PubMed ID: 13942525 [No Abstract] [Full Text] [Related]
6. Use of chelating agents in treatment of metal poisoning (with special emphasis on lead). FOREMAN H Fed Proc; 1961 Sep; 20(3)Pt 2():191-6. PubMed ID: 13894041 [No Abstract] [Full Text] [Related]
7. Biochemical and pharmacological properties of the metal-binding agent penicillamine. APOSHIAN HV Fed Proc; 1961 Sep; 20(3)Pt 2():185-8. PubMed ID: 13861903 [No Abstract] [Full Text] [Related]
8. [Method and surveillance of treatment by penicillamine during hepatolenticular degeneration and in poisonings. (Apropos of 3 cases)]. PIERI J; TRONCONI ; MOREAU ; EISINGER Mars Med; 1963; 100():51-7. PubMed ID: 13943419 [No Abstract] [Full Text] [Related]
9. [Chelating agents in lead poisoning]. ROCHE L; BADINAND A; LEJEUNE E Arch Mal Prof; 1960; 21():1-12. PubMed ID: 14438083 [No Abstract] [Full Text] [Related]
10. [The use of chelating agents in the treatment of lead poisoning]. de TAVARES JF; PORTO AL J Med (Oporto); 1961 Apr; 44():925-9. PubMed ID: 13775519 [No Abstract] [Full Text] [Related]
11. A comparison of intravenous calcium disodium versenate and oral penicillamine in promoting elimination of lead. HARRIS CE Can Med Assoc J; 1958 Oct; 79(8):664-6. PubMed ID: 13585293 [No Abstract] [Full Text] [Related]
12. The use of D-penicillamine for lead poisoning. Beattie AD Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):43-5. PubMed ID: 122672 [No Abstract] [Full Text] [Related]
13. [Unithiole therapy in lead poisoning]. Anatovskaia VS Vrach Delo; 1965 Jun; 6():84-6. PubMed ID: 5856059 [No Abstract] [Full Text] [Related]
14. Treatment of lead poisoning by chelation. COTTER LH J Am Med Assoc; 1954 Jul; 155(10):906-8. PubMed ID: 13162827 [No Abstract] [Full Text] [Related]
15. Comparison of therapeutic effects of garlic and d-Penicillamine in patients with chronic occupational lead poisoning. Kianoush S; Balali-Mood M; Mousavi SR; Moradi V; Sadeghi M; Dadpour B; Rajabi O; Shakeri MT Basic Clin Pharmacol Toxicol; 2012 May; 110(5):476-81. PubMed ID: 22151785 [TBL] [Abstract][Full Text] [Related]
16. Childhood lead poisoning and its treatment. Angle CR Annu Rev Pharmacol Toxicol; 1993; 33():409-34. PubMed ID: 8494346 [No Abstract] [Full Text] [Related]
17. Acute lead arsenate poisoning. Geddes R Aust N Z J Med; 1990 Oct; 20(5):750-1. PubMed ID: 2126731 [No Abstract] [Full Text] [Related]
18. Penicillamine and vitamin B6 interrelationships in the rat. HEDDLE JG; McHENRY EW; BEATON GH Can J Biochem Physiol; 1963 May; 41():1215-22. PubMed ID: 13963670 [No Abstract] [Full Text] [Related]
19. [Present value of chelation in therapeutics]. PERRAULT M; CLAVEL B; CHAIN F Therapie; 1956; 11(4):735-44. PubMed ID: 13352306 [No Abstract] [Full Text] [Related]
20. Chelation therapy in children exposed to lead. Shannon M; Woolf A; Binns H N Engl J Med; 2001 Oct; 345(16):1212-3. PubMed ID: 11642245 [No Abstract] [Full Text] [Related] [Next] [New Search]